These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3722954)

  • 1. [Simultaneous cytofluorometric studies on DNA and protein in endometrial adenocarcinoma--with reference to gestagen treatment].
    Ohta T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):750-8. PubMed ID: 3722954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M; Pickel H
    Zentralbl Gynakol; 1988; 110(16):1013-7. PubMed ID: 2973195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of DNA synthetic cells in endometrial carcinoma cases treated with progestogen].
    Izutsu T; Fukushima A; Kagabu T; Nishiya I
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1227-32. PubMed ID: 1431435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
    Feng YJ; Zhang XY
    Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of treatment with oral 6-methyl-17-hydroxyprogesterone acetate in endometrial adenocarcinoma. Histochemical and ultrastructural aspects].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S; Patton R
    Minerva Ginecol; 1981 Apr; 33(4):293-306. PubMed ID: 7243070
    [No Abstract]   [Full Text] [Related]  

  • 7. [Flow cytometric study on the action of progestogen in patients with adenocarcinoma and precancerous lesions of the endometrium].
    Nishiya I; Izutsu T; Satoh K; Yoshizumi N; Kurokawa Y; Kagabu T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1161-8. PubMed ID: 3161958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA and nuclear protein measurement in columnar epithelial cells of human endometrium.
    Oud PS; Reubsaet-Veldhuizen JA; Beck HL; Pahlplatz MM; Hesselmans GH; Hermkens HG; Tas J; James J; Vooijs GP
    Cytometry; 1986 Jul; 7(4):325-30. PubMed ID: 2426061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of endometrial cancer by DNA cytophotometry].
    Dietl J; Hedderich J; Sprenger E
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):796-9. PubMed ID: 3803873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between nuclear DNA content and cellular morphology in endometrial cancer--analysis by cell sorting with flow cytometry].
    Sugita M; Tenjin Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Feb; 38(2):195-202. PubMed ID: 3958516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal therapy in endometrial cancer].
    Kanoh H; Okudaira Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2306-10. PubMed ID: 8259843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
    Lindahl B; Alm P; Killander D; Långström E; Tropé C
    Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
    Lindahl B; Alm P
    Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gestagen treatment of endometrial carcinoma--theoretical and practical application].
    Sugawa T; Sako H
    Gan To Kagaku Ryoho; 1984 May; 11(5):1005-11. PubMed ID: 6721511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the malignant potentiality in superficial esophageal carcinoma by cytofluorometry of nuclear DNA and cellular protein contents--in relation to histopathologic findings and prognosis].
    Nakamura T
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):242-52. PubMed ID: 1593164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?
    Benraad TJ; Friberg LG; Koenders AJ; Kullander S
    Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.